Back to results
US 2021/0260041 A1Published application
Pharmaceutical compositions of alpha-2-adrenergic receptor agonists and their use for improving vision
AssigneeAllergan, Inc.
InventorsRichard Graham, Ke Wu, Massoud Fahid, Mohammed Dibas
Life of this patent
Estimating the term…
Abstract
Methods of using the alpha-2-adrenergic receptor agonist of Formula I: for improving vision such as in the treatment of ocular conditions such as presbyopia, poor night vision, visual glare, visual starbursts, visual halos, and some forms of myopia (e.g. night myopia) are described.
Claims64
A pharmaceutical composition comprising a compound of Formula I:
- or a pharmaceutically acceptable salt thereof, a buffer, sodium chloride, and water.
Dependencies are inferred from the claim text.